Literature DB >> 8158127

Differential requirements of sodium for coupling of cannabinoid receptors to adenylyl cyclase in rat brain membranes.

M A Pacheco1, S J Ward, S R Childers.   

Abstract

Sodium is generally required for optimal inhibition of adenylyl cyclase by Gi/o-coupled receptors. Cannabinoids bind to specific receptors that act like other members of the Gi/o-coupled receptor superfamily to inhibit adenylyl cyclase. However, assay of cannabinoid inhibition of adenylyl cyclase in rat cerebellar membranes revealed that concentrations of NaCl ranging from 0 to 150 mM had no effect on agonist inhibition. This lack of effect of sodium was not unique to cannabinoid receptors, because the same results were observed using baclofen as an agonist for GABAB receptors in cerebellar membranes. The lack of sodium dependence was region-specific, because assay of cannabinoid and opioid inhibition of adenylyl cyclase in striatum revealed an expected sodium dependence, with 50 mM NaCl providing maximal inhibition levels by both sets of agonists. This difference in sodium requirements between these two regions was maintained at the G protein level, because agonist-stimulated low Km GTPase activity was maximal at 50 mM NaCl in striatal membranes, but was maximal in the absence of NaCl in cerebellar membranes. Assay of [3H]WIN 55212-2 binding in cerebellar membranes revealed that the binding of this labeled agonist was sensitive to sodium and guanine nucleotides like other Gi/o-coupled receptors, because both NaCl and the nonhydrolyzable GTP analogue Gpp(NH)p significantly inhibited binding. These results suggest that differences in receptor-G protein coupling exist for cannabinoid receptors between these two brain regions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8158127     DOI: 10.1046/j.1471-4159.1994.62051773.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Efficacy in CB1 receptor-mediated signal transduction.

Authors:  Allyn C Howlett
Journal:  Br J Pharmacol       Date:  2004-08       Impact factor: 8.739

Review 2.  Modulation of GPCRs by monovalent cations and anions.

Authors:  Andrea Strasser; Hans-Joachim Wittmann; Erich H Schneider; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-30       Impact factor: 3.000

3.  Identification and characterization of a novel synthetic cannabinoid CP 55,940 binder in rat brain cytosol.

Authors:  J Qureshi; M Saady; A Cardounel; M Kalimi
Journal:  Mol Cell Biochem       Date:  1998-04       Impact factor: 3.396

4.  Effects of sodium on agonist efficacy for G-protein activation in mu-opioid receptor-transfected CHO cells and rat thalamus.

Authors:  D E Selley; C C Cao; Q Liu; S R Childers
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

5.  Cannabinoids enhance NMDA-elicited Ca2+ signals in cerebellar granule neurons in culture.

Authors:  J G Netzeband; S M Conroy; K L Parsons; D L Gruol
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

6.  Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum.

Authors:  G Griffin; E J Wray; B R Martin; M E Abood
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

7.  Effects of extracellular sodium on mu-opioid receptors coupled to potassium channels coexpressed in Xenopus oocytes.

Authors:  Murat Oz; Charles E Spivak
Journal:  Pflugers Arch       Date:  2003-01-18       Impact factor: 3.657

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.